Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Gossage, MD
Augusta University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California - Los Angeles
Los Angeles, California, United States
- University of Colorado
Denver, Colorado, United States
- Augusta University
Augusta, Georgia, United States
- John Hopkins University
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University of Texas - Southwestern
Dallas, Texas, United States
- University of Utah Medical Center
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 May 2023
- Primary completion
- 21 Nov 2025
- Completion
- 31 Jul 2026
- Last update posted
- 19 Mar 2026
- Registered enrollment
- 70
- Registry id
- NCT03850964
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.